ADAGE CAPITAL PARTNERS GP, L.L.C. – Vertex Pharmaceuticals Incorporated Transaction History
ADAGE CAPITAL PARTNERS GP, L.L.C. portfolio value:
$97.62M
portfolio value
ADAGE CAPITAL PARTNERS GP, L.L.C. quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -41.06% | -234.86K shares | -63.57M | $289.54 | 337.16K |
| Q2 2022 | share | Decrease | -27.89% | -221.26K shares | -45.83M | $281.79 | 572.03K |
| Q1 2022 | share | Increase | +259.13% | 572.4K shares | 158.51M | $260.97 | 793.29K |
| Q4 2021 | share | Increase | +26.98% | 46.93K shares | 16.95M | $222.45 | 220.89K |
| Q3 2021 | share | Decrease | -48.68% | -164.98K shares | -36.78M | $181.39 | 173.96K |
| Q2 2021 | share | Decrease | -61.82% | -548.8K shares | -122.42M | $201.63 | 338.94K |
| Q1 2021 | share | Increase | +30.14% | 205.6K shares | 29.54M | $214.89 | 887.74K |
| Q4 2020 | share | Increase | +134.42% | 391.15K shares | 82.03M | $236.34 | 682.14K |
| Q3 2020 | share | Decrease | -27.19% | -108.66K shares | -36.83M | $272.12 | 290.99K |
| Q2 2020 | share | Decrease | -56.13% | -511.3K shares | -100.73M | $290.31 | 399.65K |
| Q1 2020 | share | Increase | +12.50% | 101.25K shares | 39.47M | $237.95 | 910.95K |
| Q4 2019 | share | Decrease | -7.20% | -62.8K shares | 29.46M | $218.95 | 809.70K |
| Q3 2019 | share | Increase | +33.59% | 219.36K shares | 28.04M | $169.42 | 872.50K |
| Q2 2019 | share | Increase | +47.02% | 208.9K shares | 38.05M | $183.38 | 653.14K |
| Q1 2019 | share | Increase | +2.71% | 11.72K shares | 10.04M | $183.95 | 444.24K |
| Q4 2018 | share | Increase | +9.22% | 36.5K shares | -4.65M | $165.71 | 432.51K |
| Q3 2018 | share | Decrease | -54.00% | -464.89K shares | -69.99M | $192.74 | 396.01K |
| Q2 2018 | share | Increase | +30.31% | 200.22K shares | 38.64M | $169.96 | 860.90K |
| Q1 2018 | share | Decrease | -51.39% | -698.6K shares | -96.02M | $162.98 | 660.68K |
| Q4 2017 | share | Increase | +31.18% | 323.1K shares | 46.16M | $149.86 | 1.35M |
| Q3 2017 | share | Increase | +7.38% | 71.2K shares | 33.18M | $152.04 | 1.03M |
| Q2 2017 | share | Increase | +164.62% | 600.31K shares | 84.48M | $128.87 | 964.98K |
| Q1 2017 | share | Increase | +43.50% | 110.53K shares | 21.15M | $109.35 | 364.66K |
| Q4 2016 | share | Decrease | -55.88% | -321.9K shares | -31.51M | $73.67 | 254.12K |
| Q3 2016 | share | Decrease | -17.22% | -119.8K shares | -9.62M | $87.21 | 576.02K |
| Q2 2016 | share | Decrease | -32.01% | -327.54K shares | -21.49M | $86.02 | 695.82K |
| Q1 2016 | share | Decrease | -27.61% | -390.4K shares | -96.54M | $79.49 | 1.02M |